Segment disclosures

Company overview

Verrica Pharmaceuticals Inc.

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

8 dimension combinations 55 retained observations 12 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Product · Operating Segment

Product Or Service · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=us-gaap:ProductMember;us-gaap:StatementBusinessSegmentsAxis=vrca:OperatingSegmentMember
PeriodValueUnitFiledEvidence
2025-01-01 – 2025-12-3115285000 USD20260311Open filing evidence
2025-07-01 – 2025-09-303607000 USD20251114Open filing evidence
2025-01-01 – 2025-09-3011563000 USD20251114Open filing evidence
2024-01-01 – 2024-12-316574000 USD20260311Open filing evidence
2024-07-01 – 2024-09-30-1865000 USD20251114Open filing evidence
2024-01-01 – 2024-09-306259000 USD20251114Open filing evidence

Product · Reportable Segment

Product Or Service · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=us-gaap:ProductMember;us-gaap:StatementBusinessSegmentsAxis=vrca:ReportableSegmentMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-305093000 USD20260806Open filing evidence
2026-01-01 – 2026-06-309383000 USD20260806Open filing evidence
2026-01-01 – 2026-03-314290000 USD20260512Open filing evidence
2025-04-01 – 2025-06-304534000 USD20260806Open filing evidence
2025-01-01 – 2025-06-307956000 USD20260806Open filing evidence
2025-01-01 – 2025-03-313422000 USD20260512Open filing evidence

License And Collaboration Revenue · Operating Segment

Product Or Service · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=vrca:LicenseAndCollaborationRevenueMember;us-gaap:StatementBusinessSegmentsAxis=vrca:OperatingSegmentMember
PeriodValueUnitFiledEvidence
2025-01-01 – 2025-12-3120292000 USD20260311Open filing evidence
2025-07-01 – 2025-09-3010737000 USD20251114Open filing evidence
2025-01-01 – 2025-09-3018922000 USD20251114Open filing evidence
2024-01-01 – 2024-12-31992000 USD20260311Open filing evidence
2024-07-01 – 2024-09-3084000 USD20251114Open filing evidence
2024-01-01 – 2024-09-30963000 USD20251114Open filing evidence

License And Collaboration Revenue · Reportable Segment

Product Or Service · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=vrca:LicenseAndCollaborationRevenueMember;us-gaap:StatementBusinessSegmentsAxis=vrca:ReportableSegmentMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-30769000 USD20260806Open filing evidence
2026-01-01 – 2026-06-301502000 USD20260806Open filing evidence
2026-01-01 – 2026-03-31733000 USD20260512Open filing evidence
2025-04-01 – 2025-06-308168000 USD20260806Open filing evidence
2025-01-01 – 2025-06-308185000 USD20260806Open filing evidence
2025-01-01 – 2025-03-3117000 USD20260512Open filing evidence

Operating Segment

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=vrca:OperatingSegmentMember
PeriodValueUnitFiledEvidence
2025-01-01 – 2025-12-3135577000 USD20260311Open filing evidence
2025-07-01 – 2025-09-3014344000 USD20251114Open filing evidence
2025-01-01 – 2025-09-3030485000 USD20251114Open filing evidence
2025-04-01 – 2025-06-3012702000 USD20250812Open filing evidence
2025-01-01 – 2025-06-3016141000 USD20250812Open filing evidence
2025-01-01 – 2025-03-313439000 USD20250513Open filing evidence
2024-01-01 – 2024-12-317566000 USD20260311Open filing evidence
2024-07-01 – 2024-09-30-1781000 USD20251114Open filing evidence
2024-01-01 – 2024-09-307222000 USD20251114Open filing evidence
2024-04-01 – 2024-06-305177000 USD20250812Open filing evidence
2024-01-01 – 2024-06-309003000 USD20250812Open filing evidence
2024-01-01 – 2024-03-313826000 USD20250513Open filing evidence
2023-01-01 – 2023-12-315124000 USD20250311Open filing evidence

Reportable Segment

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=vrca:ReportableSegmentMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-306914000 USD20261113Open filing evidence
2026-01-01 – 2026-09-3017799000 USD20261113Open filing evidence
2026-04-01 – 2026-06-305862000 USD20260806Open filing evidence
2026-01-01 – 2026-06-3010885000 USD20260806Open filing evidence
2026-01-01 – 2026-03-315023000 USD20260512Open filing evidence
2025-07-01 – 2025-09-3014344000 USD20261113Open filing evidence
2025-01-01 – 2025-09-3030485000 USD20261113Open filing evidence
2025-04-01 – 2025-06-3012702000 USD20260806Open filing evidence
2025-01-01 – 2025-06-3016141000 USD20260806Open filing evidence
2025-01-01 – 2025-03-313439000 USD20260512Open filing evidence

Reportable Segment · Product

Statement Business Segments · Product Or Service

Source dimensions us-gaap:StatementBusinessSegmentsAxis=vrca:ReportableSegmentMember;srt:ProductOrServiceAxis=us-gaap:ProductMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-305697000 USD20261113Open filing evidence
2026-01-01 – 2026-09-3015080000 USD20261113Open filing evidence
2025-07-01 – 2025-09-303607000 USD20261113Open filing evidence
2025-01-01 – 2025-09-3011563000 USD20261113Open filing evidence

Reportable Segment · License And Collaboration Revenue

Statement Business Segments · Product Or Service

Source dimensions us-gaap:StatementBusinessSegmentsAxis=vrca:ReportableSegmentMember;srt:ProductOrServiceAxis=vrca:LicenseAndCollaborationRevenueMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-301217000 USD20261113Open filing evidence
2026-01-01 – 2026-09-302719000 USD20261113Open filing evidence
2025-07-01 – 2025-09-3010737000 USD20261113Open filing evidence
2025-01-01 – 2025-09-3018922000 USD20261113Open filing evidence